4
Changes in Ownership
enGene Therapeutics Inc. Filed Acc 0000929638-24-002002
Director acquired 120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Glickman Richard M · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 1 in the form | +120 | $0.89 | $107 | 24,675 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −120 | 0 | D |
Loading xslF345X05/form4.xml…